Abstract
Background and aims
An increased production of macrophage inflammatory proteins 1 alpha (MIP-1α) has been reported to be associated with ulcerative colitis (UC). We investigated whether a polymorphism site in MIP-1α was associated with UC in a Chinese population. Additionally, considering the abnormal lipoprotein metabolism in subjects with UC, we also sought to determine whether genetic variation in the apolipoprotein E (ApoE) gene may play a role in the development of UC.
Materials and methods
We examined the MIP-1α −906 (TA)4/(TA)6 polymorphism and the ApoE polymorphism in a cohort of 162 unrelated UC patients and 220 healthy controls by using restriction fragment length polymorphism assay.
Results
A significantly increased frequency of the MIP-1α −906 (TA)6/(TA)6 genotype (P = 0.0031, odds ratio [OR] = 1.851, 95% confidence interval [CI] 1.228–2.791), as well as of the ApoE ε4+ genotype (P < 0.001, OR = 2.869, 95% CI 1.768–4.657), in patients with UC was proven. Moreover, the carriage of both MIP-1α −906 (TA)6/(TA)6 genotype and ApoE ε4+ genotype confers greater risk for the development of UC (P < 0.001, OR = 5.432, 95% CI 2.761–10.689).
Conclusion
These findings suggest that variation in the MIP-1α and ApoE genes and their interaction may increase susceptibility to UC. Identifying these novel susceptibility genes, as well as their interactions, will help our understanding of the disease mechanisms of UC and may identify targets for developing novel treatment measures.
Similar content being viewed by others
References
Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205
Hugot JP, Zouali H, Lesage S, Thomas G (1999) Etiology of the inflammatory bowel diseases. Int J Colorectal Dis 14:2–9
MacDermott RP (1999) Chemokines in inflammatory bowel diseases. J Clin Immunol 5:266–272
Zhong W, Kolls JK, Chen H, McAllister F, Oliver PD, Zhang Z (2008) Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. Front Biosci 13:1654–1664
Papadakis KA, Targan SR (2000) The role of chemokines and chemokine receptors in mucosal inflammation. Inflamm Bowel Dis 6:303–313
Banks C, Bateman A, Payne R, Johnson P, Sheron N (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J Pathol 199:28–35
Davatelis G, Tekamp-Olson P, Wolpe SD, Hermsen K, Luedke C, Gallegos C, Coit D, Merryweather J, Cerami A (1988) Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokine properties. J Exp Med 167:1939–1944
Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177:1821–1826
Menten P, Wuyts A, Van-Damme DJ (2002) Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13:455–481
Grimm MC, Doe WF (1996) Chemokines in IBD mucosa: expression of RANTES, MIP-1α, MIP-1β and interferon inducible protein 10 by macrophages, lymphocytes, endothelial cells and granulomas. Inflammatory Bowel Dis 2:88–96
Vainer B, Nielsen OH, Horn T (1998) Expression of E-selectin, sialyl Lewis X, and macrophage inflammatory protein-1alpha by colonic epithelial cells in ulcerative colitis. Dig Dis Sci 43:596–608
Ajuebor MN, Kunkel SL, Hogaboam CM (2004) The role of CCL3/macrophage inflammatory protein-1alpha in experimental colitis. Eur J Pharmacol 497:343–349
Al-Sharif FM, Makki RF, Ollier WE, Hajeer AH (1999) A new microsatellite marker within the promoter region of the MIP-1A gene. Immunogenetics 49:740–741
Hagberg JM, Wilund KR, Ferrell RE (2000) APOE gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics 4:101–108
Ripollés Piquer B, Nazih H, Bourreille A, Segain JP, Huvelin JM, Galmiche JP, Bard JM (2006) Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system. Metabolism 55:980–988
Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane AM, Dulak J, Rimbach G (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Comm 357:319–324
Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6
Wang B, Jin F, Xie Y, Tang Y, Kan R, Zheng C, Yang Z, Wang L (2006) Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer’s disease. Neurosci Lett 409:179–181
Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565–568
Luster AD (1998) Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445
MacDermott RP, Sanderson IR, Reinecker HC (1998) The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn’s disease. Inflam Bowel Dis 4:54–67
Pender SL, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R, MacDonald TT (2005) Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut 54:1114–1120
Choi SJ, Oba T, Callander NS, Jelinek DF, Roodman GD (2003) AML-1A and AML-1B regulation of MIP-1 alpha expression in multiple myeloma. Blood 101:3778–3783
Broedl UC, Schachinger V, Lingenhel A, Lehrke M, Stark R, Seibold F, Göke B, Kronenberg F, Parhofer KG, Konrad-Zerna A (2007) Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflamm Bowel Dis 13:391–397
Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y (1997) Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:1438–1445
Wong SY, Lau EM, Li M, Chung T, Sham A, Woo J (2005) The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese. J Bone Miner Metab 23:261–265
Ulivieri FM, Lisciandrano D, Ranzi T, Taioli E, Cermesoni L, Piodi LP, Nava MC, Vezzoli M, Bianchi PA (2000) Bone mineral density and body composition in patients with ulcerative colitis. Am J Gastroenterol 95:1491–1494
Jofre-Monseny L, Minihane AM, Rimbach G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52:131–145
Vitek MP, Brown CM, Colton CA (2008) APOE genotype-specific differences in the innate immune response. Neurobiol Aging Dec 20; [Epub ahead of print]
Lynch JR, Tang W, Wang H, Vitek MP, Bennett ER, Sullivan PM, Warner DS, Laskowitz DT (2003) APOE genotype and an ApoE mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem 278:48529–48533
Ophir G, Amariglio N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM (2005) Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis 20:709–718
Acknowledgments
The authors wish to thank all the participants and researchers who took participation in the study. This work was supported by a grant from Harbin Engineering University (Project No. HEUFT06007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, K., Wang, B., Sui, H. et al. Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis. Int J Colorectal Dis 24, 13–17 (2009). https://doi.org/10.1007/s00384-008-0575-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-008-0575-0